Increased plasma levels of S100A8, S100A9, and S100A12 in chronic spontaneous urticaria

被引:3
|
作者
Zhou, Qjong-Yan [1 ]
Lin, Wei [2 ]
Zhu, Xiao-Xia [3 ]
Xu, Su-Ling [1 ]
Ying, Meng-Xia [1 ]
Shi, Lei [1 ]
Lin, Bing-Jiang [3 ]
机构
[1] Ningbo Univ, Med Sch, Affiliated Hosp, Dept Dermatol, 247 Renmin Rd, Ningbo 315020, Zhejiang, Peoples R China
[2] Ningbo Univ, Med Sch, Affiliated Hosp, Dept Pharm, Ningbo, Zhejiang, Peoples R China
[3] Ningbo First Hosp, Dept Dermatol, Ningbo, Zhejiang, Peoples R China
关键词
Chronic spontaneous urticaria; DISEASE-ACTIVITY; MAST-CELL; PROTEINS; EXPRESSION; MANAGEMENT; RECEPTOR; RELEASE; INFLAMMATION; ACTIVATION; DIAGNOSIS;
D O I
10.4103/ijd.IJD_375_18
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Chronic spontaneous urticaria (CSU) is a skin disorder with an important immunologic profile. S100A8, S100A9, and S100A12 are the members of S100 family that have been reported to play important role in autoimmune diseases, but the characteristics of these three S100 members have not been defined in CSU. Aims: This study was performed to investigate the levels of these three S100s in patients with CSU and to study whether they were associated with the severity and clinical characteristics of CSU. Materials and Methods: The levels of plasma S100A8, S100A9, and S100A12 were measured in 51 CSU patients and 20 healthy controls using enzyme linked immunosorbent assay kits. The values in the patient group and that of the healthy controls were statistically compared. The relationships between the different markers were evaluated by correlation analysis. Results: The plasma levels of S100A8, S100A9, and S100A12 were significantly higher in CSU patients than those in controls. Interestingly, the level of S100A12 was significantly correlated with S100A8 and S100A9 in CSU patients (P < 0.05 and P < 0.001, respectively). In addition, S100A8, S100A9, and S100A12 were all significantly inversely correlated with blood basophil percentage. Conclusions: Plasma S100A8, S100A9, and S100A12 levels were elevated in CSU patients. They might be useful biomarkers of CSU, with the potential role in the pathogenesis of CSU.
引用
收藏
页码:441 / 446
页数:6
相关论文
共 50 条
  • [1] S100A8, S100A9 and S100A12 proteins in rheumatoid arthritis
    Baillet, A.
    REVUE DE MEDECINE INTERNE, 2010, 31 (06): : 458 - 461
  • [2] Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunity
    Xia, Pengpeng
    Ji, Xingduo
    Yan, Li
    Lian, Siqi
    Chen, Ziyue
    Luo, Yi
    IMMUNOLOGY, 2024, 171 (03) : 365 - 376
  • [3] Serum S100A8/S100A9 and S100A12 As a Marker Of Disease Activity In Giant Cell Arteritis
    Springer, Jason
    Holzinger, Dirk
    Hoffman, Gary S.
    Monach, Paul A.
    Hamilton, Thomas
    Langford, Carol A.
    Foell, Dirk
    Cuthbertson, David
    O'Rourke, Colin
    Carette, Simon
    Khalidi, Nader A.
    McAlear, Carol
    Pagnoux, Christian
    Seo, Philip
    Warrington, Kenneth J.
    Ytterberg, Steven R.
    Vogl, Thomas
    Merkel, Peter A.
    Roth, Johannes
    Hajj-Ali, Rula
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S706 - S706
  • [4] S100A8 and S100A9 in Cancer
    Chen, Yu
    Ouyang, Yuzhen
    Li, Zhixin
    Wang, Xiufang
    Ma, Jian
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [5] Analysis of Plasma Levels and Polymorphisms of S100A8/9 and S100A12 in Patients With Acute Pancreatitis
    Farkas, Gyula, Jr.
    Tiszlavicz, Zoltan
    Takacs, Tamas
    Szabolcs, Annamaria
    Farkas, Gyula
    Somogyvari, Ferenc
    Mandi, Yvette
    PANCREAS, 2014, 43 (03) : 485 - 487
  • [6] Secretion of S100A8, S100A9, and S100A12 by Neutrophils Involves Reactive Oxygen Species and Potassium Efflux
    Tardif, Melanie R.
    Chapeton-Montes, Julie Andrea
    Posvandzic, Alma
    Page, Nathalie
    Gilbert, Caroline
    Tessier, Philippe A.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [7] Prognostic significance of peripheral blood S100A12, S100A8, and S100A9 concentrations in idiopathic pulmonary fibrosis
    Ding, Dongyan
    Luan, Rumei
    Xue, Qianfei
    Yang, Junling
    CYTOKINE, 2023, 172
  • [8] Chemotactic activity of S100A8 and S100A9
    Roth, J
    Vogl, T
    Sunderkötter, C
    Sorg, C
    JOURNAL OF IMMUNOLOGY, 2003, 171 (11): : 5651 - 5651
  • [9] S100A8 and S100A9 in experimental osteoarthritis
    Zreiqat, Hala
    Belluoccio, Daniele
    Smith, Margaret M.
    Wilson, Richard
    Rowley, Lynn A.
    Jones, Katie
    Ramaswamy, Yogambha
    Vogl, Thomas
    Roth, Johannes
    Bateman, John F.
    Little, Christopher B.
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (01)
  • [10] S100A8 and S100A9 in inflammation and cancer
    Gebhardt, Christoffer
    Nemeth, Julia
    Angel, Peter
    Hess, Jochen
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) : 1622 - 1631